The Age · Business / Companies

Why ‘Big Pharma’ isn’t cashing in on the peptide craze

· By Kishor Napier-Raman
Story summary

The most popular peptides being bought illegally in Australia are yet to attract serious attention from big pharmaceutical companies, who believe they would not be lucrative or safe enough products to bring to the legitimate market.

Read at The Age

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.